Patricia Eckert - Aug 20, 2025 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Chief Financial Officer
Signature: /s/ Patricia Eckert
Stock symbol: ENZB
Transactions as of: Aug 20, 2025
Transactions value $: $0
Form type: 4
Date filed: 8/20/2025, 08:27 AM
Previous filing: Jul 25, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Eckert Patricia	Chief Financial Officer	C/O ENZO BIOCHEM, INC., 21 EXECUTIVE BLVD., FARMINGDALE	/s/ Patricia Eckert	2025-08-20	0001952777

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZB	Common Stock	Disposed to Issuer		-28.3K	-100%		0	Aug 20, 2025	401k	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Date	Underlying Class	Amount	Ownership	Footnotes
transaction	ENZB	Stock Option (to acquire shares of Common Stock)	Disposed to Issuer	-100K	-100%	Aug 20, 2025	Common Stock	100K	Direct	F2
transaction	ENZB	Stock Option (to acquire shares of Common Stock)	Disposed to Issuer	-75K	-100%	Aug 20, 2025	Common Stock	75K	Direct	F2
transaction	ENZB	Stock Option (to acquire shares of Common Stock)	Disposed to Issuer	-25K	-100%	Aug 20, 2025	Common Stock	25K	Direct	F2
transaction	ENZB	Stock Option (to acquire shares of Common Stock)	Disposed to Issuer	-50K	-100%	Aug 20, 2025	Common Stock	50K	Direct	F2
transaction	ENZB	Stock Option (to acquire shares of Common Stock)	Disposed to Issuer	-25K	-100%	Aug 20, 2025	Common Stock	25K	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Patricia Eckert is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
F2	Pursuant to the Merger Agreement, at the Effective Time, each option that was outstanding as of immediately prior to the Effective Time was automatically, and without any required action on the part of the Reporting Person, canceled without any cash payment or other consideration being made in respect thereof.

Content

The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

Pursuant to the Merger Agreement, at the Effective Time, each option that was outstanding as of immediately prior to the Effective Time was automatically, and without any required action on the part of the Reporting Person, canceled without any cash payment or other consideration being made in respect thereof.